

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News

Synergistic Anticancer Activity of Eribulin Plus Palbociclib in Patient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer
Synergistic Anticancer Activity of Eribulin Plus Palbociclib inPatient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer

Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy
Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism



Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures
Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures